Nisa Investment Advisors’s GSK GSK Stock Holding History

Nisa Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.6K	Buy	467 +323	+224%	+$17.1K	﹤0.01%	2129
2026 Q1	$7.99K	Buy	144 +67	+87%	+$3.63K	﹤0.01%	2315
2025 Q4	$3.79K	Buy	+77	New	+$3.59K	﹤0.01%	2506
2020 Q3	–	Sell	-880	Closed	-$45K	–	2255
2020 Q2	$45K	Hold	880	–	–	﹤0.01%	1604
2020 Q1	$42K	Hold	880	–	–	﹤0.01%	1562
2019 Q4	$52K	Hold	880	–	–	﹤0.01%	1521
2019 Q3	$47K	Hold	880	–	–	﹤0.01%	1538
2019 Q2	$44K	Hold	880	–	–	﹤0.01%	1520
2019 Q1	$46K	Hold	880	–	–	﹤0.01%	1534
2018 Q4	$42K	Hold	880	–	–	﹤0.01%	1466
2018 Q3	$44K	Buy	+880	New	+$44.7K	﹤0.01%	1484

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nisa Investment Advisors's GSK Position: Q2 2026 in Review

Nisa Investment Advisors increased its GSK (GSK) stake by 224% in Q2 2026, buying an estimated $17.1K and bringing the position to 467 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

Nisa Investment Advisors first reported a position in GSK in Q3 2018 and has held it in 11 quarters since. The position peaked at $52K in Q4 2019. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Nisa Investment Advisors held 467 shares of GSK worth $24.6K as of Q2 2026.
Nisa Investment Advisors bought 323 GSK shares in Q2 2026, an estimated $17.1K.
GSK made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2129 holding.
Nisa Investment Advisors first reported a position in GSK in Q3 2018 and has held it in 11 quarters since.
Nisa Investment Advisors's GSK position peaked at $52K in Q4 2019.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.